BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2173022)

  • 1. Depression and antidepressant therapy: receptor dynamics.
    Zemlan FP; Garver DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):503-23. PubMed ID: 2173022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning.
    Sugrue MF
    Pharmacol Ther; 1983; 21(1):1-33. PubMed ID: 6312466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S
    Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental basis for the antidepressant action of the GABA receptor agonist progabide.
    Bartholini G
    Neurosci Lett; 1984 Jun; 47(3):351-5. PubMed ID: 6089056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
    Charney DS; Menkes DB; Heninger GR
    Arch Gen Psychiatry; 1981 Oct; 38(10):1160-80. PubMed ID: 6271089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
    Sulser F
    J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.
    Assie MB; Charveron M; Palmier C; Puozzo C; Moret C; Briley M
    Neuropharmacology; 1992 Feb; 31(2):149-55. PubMed ID: 1313158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for 5-HT in the action of antidepressant drugs.
    Cowen PJ
    Pharmacol Ther; 1990; 46(1):43-51. PubMed ID: 2181490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain--similarities and differences.
    Green AR; Heal DJ; Goodwin GM
    Ciba Found Symp; 1986; 123():246-67. PubMed ID: 3028726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta adrenergic receptor function in depression and the effect of antidepressant drugs.
    Pandey GN; Sudershan P; Davis JM
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():66-79. PubMed ID: 2984893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
    Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple serotonin receptors and their physiological significance.
    Peroutka SJ; Snyder SH
    Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.
    Lafaille F; Welner SA; Suranyi-Cadotte BE
    J Psychiatry Neurosci; 1991 Nov; 16(4):209-14. PubMed ID: 1664741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.